Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Revenue (2018 - 2025)

Neurogene's Revenue history spans 6 years, with the latest figure at -$80000.0 for Q1 2025.

  • For Q1 2025, Revenue fell 2566.67% year-over-year to -$80000.0; the TTM value through Dec 2025 reached -$80000.0, down 108.68%, while the annual FY2024 figure was $925000.0, N/A changed from the prior year.
  • Revenue reached -$80000.0 in Q1 2025 per NGNE's latest filing, down from $925000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $925000.0 in Q2 2024 to a low of -$80000.0 in Q1 2025.
  • Average Revenue over 3 years is $209750.0, with a median of -$3000.0 recorded in 2023.
  • Peak YoY movement for Revenue: changed 0.0% in 2024, then crashed 2566.67% in 2025.
  • A 3-year view of Revenue shows it stood at -$3000.0 in 2023, then surged by 30933.33% to $925000.0 in 2024, then plummeted by 108.65% to -$80000.0 in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Revenue are -$80000.0 (Q1 2025), $925000.0 (Q2 2024), and -$3000.0 (Q1 2024).